ALL Metrics
-
Views
-
Downloads
Get PDF
Get XML
Cite
Export
Track
Research Article
Revised

A novel genotyping method to determine copy number in a mouse line commonly used for inducible transgene expression in brain and spinal cord

[version 2; peer review: 1 approved, 2 approved with reservations]
* Equal contributors+ Deceased author
PUBLISHED 10 Feb 2022
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS

This article is included in the Genomics and Genetics gateway.

Abstract

Background: The NEFH-tTA mouse has the human neurofilament heavy polypeptide promoter directing tetracycline-controlled transactivator protein (tTa) expression to the brain and spinal cord, allowing tissue-specific and doxycycline-suppressible expression of a target gene. Current genotyping protocols can only differentiate between wild-type and transgenic animals. Being able to differentiate between hemizygous and homozygous animals would be beneficial in experiment planning and reducing animal numbers.
Methods: We have identified the insertion site of the NEFH-tTA transgene via targeted locus amplification and next-generation sequencing. This was then used to design a multiplex PCR assay to distinguish between hemizygous and homozygous mice.
Results: The NEFH-tTA transgene is located on chromosome 12. Our genotyping method can identify hemizygous and homozygous mice.
Conclusions: The NEFH-tTA transgenic mouse line is a useful tool for studying a wide range of diseases including frontotemporal dementia and motor neuron disease, as well as other neurodevelopmental, neuromuscular or neurodegenerative disorders. We have designed and utilised a novel genotyping assay to distinguish between hemizygous and homozygous mice, involving a simple PCR assay. This is easily adaptable to a laboratory-specific protocol or machine, and will allow refinement of breeding strategies and a reduction in the number of animals that cannot be used in experiments.

Keywords

NEFH-tTA, frontotemporal dementia, FTD, ALS, targeted locus amplification, genotyping, mouse

Revised Amendments from Version 1

Following constructive feedback from 3 reviewers, we have made some minor changes to this manuscript. The main changes are detailed below:

- The phrase "copy number" has been changed to "zygosity" in the title
- Fig 3 which was a pie chart has been removed and replaced with Table 5
- A FASTA file showing the sequence of the transgene has been Underlying Data repository, which can be found here https://figshare.com/articles/dataset/FASTA_reference_file_for_the_NEFH-tTA_transgene/16847170

See the authors' detailed response to the review by Keiichi Ishihara
See the authors' detailed response to the review by Virginia Lee and Mandana Hunter
See the authors' detailed response to the review by Sandy S. Pineda

Abbreviations

NEFH, neurofilament heavy polypeptide promoter; TG, transgene; tTA, tetracycline-controlled transactivator protein; TRE, tetracycline response element; TLA, targeted locus amplification.

Introduction

The NEFH-tTA mouse has the human neurofilament heavy polypeptide promoter directing tetracycline-controlled transactivator protein (tTA) expression to large-calibre axons of the brain and spinal cord, allowing tissue-specific and doxycycline-suppressible expression of a target gene1. The line was generated via pronuclear injection of a plasmid with the human NEFH promoter isolated from BAC clone (CHORI: RP11-91J21) to drive expression of the tetracycline transactivator gene, which randomly integrated into the genome1. While a genotyping protocol is available to distinguish between wild-type and transgenic animals1, ideally a colony of homozygous animals would be maintained for experimental breeding with another transgenic line with the gene of interest under the control of a tetracycline response element (TRE). All offspring of these breeds would therefore be NEFH-tTA+/- (which has been shown to be a sufficient driver of expression1); this would allow use of littermate controls and reduce required breeding numbers as encouraged by the ARRIVE guidelines2. In order to address this, we have identified the insertion site of the NEFH-tTA transgene, designed a novel PCR genotyping strategy, and demonstrated its reliability in a colony of NEFH-tTA mice.

Methods

Ethical statement

All animal work was approved following local ethical review by the University of Manchester Animal Welfare and Ethical Review Board and performed under Home Office project license 70/8903 and in accordance with the Home Office (Animals) Scientific Procedures Act (1986). All efforts were made to ameliorate harm to animals; mice were housed and maintained according to standard practices in the University of Manchester Biological Services Facility (detailed below) and no licenced procedures were performed.

Maintenance of transgenic mice

B6;C3-Tg(NEFH-tTA)8Vle/J mice (JAX stock #025397) were obtained from Jackson Laboratories (Bar Harbor, ME, USA) and bred with C57BL6/J mice to produce a colony of hemizygous NEFH-tTA animals (13 transgenic mice were crossed with 12 wild-type in total, as this number was sufficient to create a new colony of backcrossed mice). All animal work was carried out in the University of Manchester Biological Services Facility. Mice had free access to food and water and were housed under light-humidity- and temperature-controlled conditions: ambient temperatures of 21°C (±2°C), humidity of 40–50%, 12 h light cycle, ad libitum access to water and standard rodent chow. Animals were housed up to five per cage with environmental enrichment. For breeding, mice were housed as either breeding pairs or trios of two female and one male, and pups housed with parents until weaning (approximately four weeks post-birth).

At weaning, animals were restrained by scruffing and ear biopsies were taken using a standard ear puncher and genotyped as described1. Briefly, tissue was disrupted in proteinase K for one hour at 57°C; reactions containing 3μL of diluted DNA, 10μL PrimeSTAR HS Premix (Takara, Clontech #R040A) and 0.5μM each of forward and reverse transgene primers and internal positive control primers (Primers 1–4, Table 1) in a total volume of 20μL were amplified in a thermal cycler (ThermoFisher SimpliAmpTM A24812; Table 2). PCR products were visualised on a 2% agarose gel with HyperLadder IV (Bioline) to determine product size.

Table 1. Genotyping primer sequences.

No.Sequence
1CTC GCG CAC CTG CTG AATTransgene allele detection1
2CAG TAC AGG GTA GGC TGC TCTransgene allele detection
3CTA GGC CAC AGA ATT GAA AGA TCTInternal control1
4GTA GGT GGA AAT TCT AGC ATC ATC CInternal control
5TCATGGAGACACCAATGACGWild-type detection
6GGAGGAATTCATGTGCCACTWild-type detection

Table 2. PCR reaction conditions.

StageTemperatureTime
195°C20 sec
2
10x
95°C20 sec
65°C15 sec- 0.5°C per cycle
68°C10 sec
3
28x
95°C15 sec
62°C15 sec
70°C30 sec
472°C2 minutes
4°C

Identification of the transgene insertion point

A combination of targeted locus amplification (TLA) and next-generation sequencing was used to identify the insertion point of the NEFH-tTA transgene (the FASTA of the transgene sequence can be viewed in the Underlying data). This was performed by Cergentis B.V (Utrecht, The Netherlands). One mouse spleen was dissected from a six-week old NEFH-tTA+/- mouse (culled by Schedule 1 CO2 inhalation) and cells isolated for TLA sample prep. Spleen tissue was disrupted by gently pushing through a 40µm mesh and cells collected in PBS with 10% foetal calf serum (Gibco #10500064). Cells were pelleted by centrifugation at 250g for ten minutes at room temperature, resuspended in lysis buffer (0.15M NH4CL, 0.01M KHCO3, 0.0002M EDTA) and incubated at room temperature for five minutes before additional centrifugation at 250g for ten minutes. Cells were resuspended in PBS with 10% foetal calf serum (Gibco #10500064), stored at -80°C and shipped to Cergentis on dry ice.

Two primer sets (Table 3) were used in individual TLA amplifications. PCR products were purified and library prepped using the Illumina NexteraXT protocol and sequenced on an Illumina sequencer. Reads were mapped using BWA-SW, which is a Smith-Waterman alignment tool. This allows partial mapping, which is optimally suited for identifying break-spanning reads. The mouse genome version mm10 (GenBank assembly accession: GCA_000001635.2) was used for mapping.

Table 3. Targeted locus amplification primers.

Primer SetDirectionBinding pos.Sequence
1Fw6590GACAGAATAGCAGTACCCAC
Rv6428GACAAGGTTCTAGCAGTATTAAT
2Fw16557TCTCCTGTCTCCGTTCTATGGA
Rv16206GCTGGGCTGAGTTTGAGGG

Genotyping of offspring from hemizygous intercross matings

Hemizygous mice were bred together (total 25 animals; the number of breeding animals was chosen based on expected number of homozygous offspring and numbers required to set up a large colony to breed with a different transgenic line3) and ear biopsies taken from all offspring at weaning (n=50) as described above. Primers were designed using Primer3 (web version 4.1.0) to produce a product spanning the insertion site on chromosome 12 (Primers 5-6, Table 1) and PCR reactions were set up as described under Maintenance of transgenic mice. REDExtract-N-Amp™ 2X PCR Reaction Mix (Sigma-Aldrich, #R4775) was used instead of PrimeStar.

Statistical analysis

Outcome vs Expected for genotype was performed using GraphPad Prism version 8.00 for Mac (GraphPad Software, La Jolla California USA, www.graphpad.com).

Results

The NEFH-tTA transgene is located on chromosome 12

Using TLA highest coverage is observed on the sequences directly surrounding the location of the primer set. Here, high coverage is observed on chromosome 12, outlined in red in Figure 1A, indicating the transgene (TG) has integrated in chromosome 124.

d9f0d705-9025-4b83-82be-5651b11019d2_figure1.gif

Figure 1.

(A) Targeted locus amplification (TLA) sequence coverage across the mouse genome using primer set 1. The chromosomes are indicated on the y-axis, the chromosomal position on the x-axis. Similar results were obtained with primer set 2 (see Underlying data4). (B) TLA sequence coverage across mouse chromosome 12 with primer pair 1. The arrow points towards the integration site. (C) TLA sequence coverage across the TG with primer pair 1 (top) and 2 (bottom).

From locus-wide coverage (Figure 1B) we were able to identify the junction sites between the TG and the mouse genomic sequence, and it was concluded that the TG has integrated in mouse chr12:6917896-chr12:6917912. Reads marking the TG integration are identified in Table 4. The 11 bases between chr12:6917896-chr12:6917912 have been deleted following the integration event. According to the reference sequence (mm10) there are no genes annotated in this region. Complete coverage is observed across the whole TG sequence from TG:68-18543 (Figure 1C). At the edges of the coverage, fusion reads have been found, connecting these ends, but the TG: 1 -68 and TG 18544 – end regions are not integrated into the mouse genome (Table 4). These regions contained sequences for bacterial DNA replication and therefore are not required for transgenic expression in the mouse.

Table 4. Transgenic insertion sites and fusion sequences.

Homologous sequences are shown in purple.

Join site 1Join site 2Sequence
5'
integration
chr12:6917896 (-)TG:15950 (-)CCTTTGCAGGCTTGTTAGATGAATGTCATCATGGAGACACCAATGACGGCACAATGGCAGTCAA
ATGACCATCACACCAAGGGATGTTCCACTTTGAGGGGTCTCTGGCTGAACTGGGGATGGGGAA CCCACATCTTGCCGTTCTGTCAA
3'
integration
TG:7482 (-)chr12:6917912 (+)CGCTCTTCAATCTTCCGAGGCCGGATGAAGCATTCGGGCGTTCCCACTGCGGAAGGGCGGGG
ATGGCTGTGACGCAGGCGTGCCCGCCGTCGCCTGCTAACTTATCATCACTTGAATTGATGGCAT
AGCTTCCTGGTGTGAACCAATGACAGTTTTAATCTATTTCTGGGATCTTTCTCCAAAAATTGCAA AAGATAGTTTAATCATATGTGTAACATG
Fusion
read
TG:18537 (-)TG:74 (+)CCTCATCCTCCATGTCCTTTCTCTGTGGAGCCGTGTGCCCTGCACATATCTAAGTACATGCTGG
GGATGCGGTTGGCTCTATGGCTTCTGAGGCGGAAAGAACCAGCTGGGGCTCGAACGCGTTGACATTGATTATTGACTAGTTATTAAT
TG-TG
fusion 1
TG:7926 (-)TG:70 (+)GATTAGAGGTGTGAGCCACTGCACCGCCGAAAGTGGGTTTGATGACAATGTTGTGAGGCTAGCGTTGACATTGATTATTGACTAGTTATTAATAG
TG-TG
fusion 2
TG:3745 (+)TG:4793 (+) ATCTCAACTCACTGCAGCCTTGACCTCCTGGGCTCAAGCGATCCACCCACTTCATCCTCCCTAGTAGTTGGGACTACAGGTGCCTGCCAACACACC
TG-TG
fusion 3
TG:7576 (-) TG:7714 (-)GGGGGCGCTGTTGCTGGCGCGATTCTATCAAGCGCAGAGCCAGCCGAGGCAGTATGCCGAGG
CAGAGAAACCGGTTCTGCTGTCCCAGGGCCTCGGGAGGCTGAGGTGGGAGGATCGCTTAAAC CTGGAGAGGCGGAGGTTGCAGTGAGCCGAGATCACGCCACGGCACTCCAGCCTCGGCAACAG AGCGAGACCCTGTCACAAACGAACA
TG-TG
fusion 4
TG:11034 (-) TG:11295 (-)TTTAAACTCTGGCATGAATCTTTCTCTCAAATGTACTATGGGCTCCCTCCTTCTCCCCCAGAATA
AGAGATGAAACAGCTTTGTCATCCTTTACGTGGTGGGCACCTGCCTGCTGTGCTCCACGTACATACGTGGTGTCTGCAACAACTCTGTCAGCTGTGCAA
GGTCACTGTCCTCTAC

Next to the head-to-tail fusion as reported above, four other TG-TG fusions were found within the TG sequence (Table 4). While an exact copy number cannot be determined using TLA, an estimation can be made based on the number of integration sites, number of fusion reads and the ratio of coverage on the TG and genome integration site. Here, one integration site was found and a total of five TG-TG fusions were found. The coverage at the TG was significantly higher compared to the genome. These facts together suggest that >5 copies of the TG may have integrated.

Design of a PCR assay to distinguish between hemizygous and homozygous transgenic mice

We designed primers to amplify a wild-type PCR product of 488bp from chromosome 12, which would be disrupted by insertion of the transgenic allele (Figure 2A). A multiplex PCR reaction including the original primers to the transgene1 (Table 1) was carried out on samples from a hemizygous intercross and proved able to distinguish between wild-type (488bp band only), hemizygous (both bands) and homozygous (150bp band only) (Figure 2B)4.

d9f0d705-9025-4b83-82be-5651b11019d2_figure2.gif

Figure 2. Genotyping strategy for homozygous mice.

(A) Primer design to produce a wild-type product that is disrupted in the presence of the transgenic allele. (B) Samples visualised on a 2% agarose gel showing wild-type (top band), homozygous (bottom band) and hemizygous (both bands) animals.

Homozygous NEFH-tTA mice are observed at the same rate as expected

After genotyping 50 offspring of hemizygous intercrosses we observed no significant difference in the number of Nefh-tTA+/+ mice compared to the expected ratio (Table 5, chi-square=2.64, p<0.26714), confirming our novel genotyping assay performs as expected. Homozygous mice grew to adulthood and did not exhibit any overt phenotype.

Table 5. Numbers of pups of each genotype observed using our novel PCR assay in litters from hemizygous intercrosses compared to numbers which would be expected based on Mendelian inheritance patterns.

A chi-square test was performed (using GraphPad Prism version 7.04) to confirm that the observed numbers were not significantly different to expected, indicating that our genotyping method works as predicted.

GenotypeNumber expectedNumber observedPercentage of total expectedPercentage of total observed
Nefh-tTA-/-12.5162532
Nefh-tTA+/-25265052
Nefh-tTA+/+12.582516
TOTAL:5050100100
Chi-square value:2.64
P value (two-tailed):0.2671
Significance:Not significant

Discussion/conclusion

The NEFH-tTA transgenic mouse line is a useful tool for studying a wide range of diseases including frontotemporal dementia and motor neurone disease, as well as other neurodevelopmental, neuromuscular or neurodegenerative disorders. Here we have shown that the transgene has inserted into chromosome 12. Furthermore, we have designed and utilised a novel genotyping assay to distinguish between hemizygous and homozygous mice, involving a simple PCR assay. This is easily adaptable to a laboratory-specific protocol or machine and will allow researchers using this line to refine their breeding strategies and reduce the number of animals that cannot be used in experiments.

Data availability

Underlying data

Figshare: “A novel genotyping method to determine zygosity in a mouse line commonly used for inducible transgene expression in brain and spinal cord – Raw data/analysis” DOI: https://doi.org/10.6084/m9.figshare.12982220.v14.

This project contains the following underlying data:

  • - Nefh o vs e.pzfx (raw data and analysis for Table 5)

  • - Nefh o vs e.xlsx (raw data and analysis for Table 5)

  • - TLA and seq data – Cergentis report 2017UMAN0801.pdf (all sequencing and TLA data received from Cergentis)

  • - Raw data – PCR gel image.tif (original, unedited PCR gel image from Figure 2)

Figshare: FASTA reference file for the NEFH-tTA transgene, https://doi.org/10.6084/m9.figshare.16847170.v15

This project contains the following underlying data:

  • FASTA reference file for the NEFH.docx

Data are available under the terms of the Creative Commons Zero "No rights reserved" data waiver (CC0 1.0 Public domain dedication).

Comments on this article Comments (0)

Version 2
VERSION 2 PUBLISHED 15 Oct 2020
Comment
Author details Author details
Competing interests
Grant information
Copyright
Download
 
Export To
metrics
Views Downloads
F1000Research - -
PubMed Central
Data from PMC are received and updated monthly.
- -
Citations
CITE
how to cite this article
Hobbs E, Ryan S, Rollinson S et al. A novel genotyping method to determine copy number in a mouse line commonly used for inducible transgene expression in brain and spinal cord [version 2; peer review: 1 approved, 2 approved with reservations]. F1000Research 2022, 9:1249 (https://doi.org/10.12688/f1000research.26550.2)
NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status: ?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions
Version 2
VERSION 2
PUBLISHED 10 Feb 2022
Revised
Views
6
Cite
Reviewer Report 31 Mar 2022
Keiichi Ishihara, Department of Pathological Biochemistry, Division of Pathological Sciences, Kyoto Pharmaceutical University, Kyoto, Japan 
Approved
VIEWS 6
The manuscript ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Ishihara K. Reviewer Report For: A novel genotyping method to determine copy number in a mouse line commonly used for inducible transgene expression in brain and spinal cord [version 2; peer review: 1 approved, 2 approved with reservations]. F1000Research 2022, 9:1249 (https://doi.org/10.5256/f1000research.116746.r123131)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
Version 1
VERSION 1
PUBLISHED 15 Oct 2020
Views
10
Cite
Reviewer Report 28 Apr 2021
Sandy S. Pineda, Brain and Mind Centre, University of Sydney, Sydney, Australia 
Approved with Reservations
VIEWS 10
In the manuscript entitled: “A novel genotyping method to determine copy number in a mouse line commonly used for inducible transgene expression in brain and spinal cord”, by Hobbs and colleagues, they present the use of TLA (Targeted locus amplification) ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Pineda SS. Reviewer Report For: A novel genotyping method to determine copy number in a mouse line commonly used for inducible transgene expression in brain and spinal cord [version 2; peer review: 1 approved, 2 approved with reservations]. F1000Research 2022, 9:1249 (https://doi.org/10.5256/f1000research.29310.r79860)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
  • Author Response 10 Feb 2022
    Sarah Ryan, Division of Neuroscience and Experimental Psychology, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PL, UK
    10 Feb 2022
    Author Response
    We thank Dr Pineda for reviewing the manuscript, and are grateful for the constructive comments. There were some points to be addressed, as follows:

    Could the authors include an ... Continue reading
COMMENTS ON THIS REPORT
  • Author Response 10 Feb 2022
    Sarah Ryan, Division of Neuroscience and Experimental Psychology, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PL, UK
    10 Feb 2022
    Author Response
    We thank Dr Pineda for reviewing the manuscript, and are grateful for the constructive comments. There were some points to be addressed, as follows:

    Could the authors include an ... Continue reading
Views
15
Cite
Reviewer Report 28 Apr 2021
Keiichi Ishihara, Department of Pathological Biochemistry, Division of Pathological Sciences, Kyoto Pharmaceutical University, Kyoto, Japan 
Approved with Reservations
VIEWS 15
Eleanor Hobbs et al. in this paper, have identified the integrated site of the transgene in the B6;C3-Tg(NEFH-tTA)8Vle/J mice by TLA and also have developed a simple PCR method to distinguish for hemizygous and homozygous. The manuscript is well written, but ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Ishihara K. Reviewer Report For: A novel genotyping method to determine copy number in a mouse line commonly used for inducible transgene expression in brain and spinal cord [version 2; peer review: 1 approved, 2 approved with reservations]. F1000Research 2022, 9:1249 (https://doi.org/10.5256/f1000research.29310.r83325)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
  • Author Response 10 Feb 2022
    Sarah Ryan, Division of Neuroscience and Experimental Psychology, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PL, UK
    10 Feb 2022
    Author Response
    We thank Prof Ishihara for reviewing the manuscript, and are grateful for the constructive comments. There were some points to be addressed, as follows:

    How many times were the ... Continue reading
COMMENTS ON THIS REPORT
  • Author Response 10 Feb 2022
    Sarah Ryan, Division of Neuroscience and Experimental Psychology, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PL, UK
    10 Feb 2022
    Author Response
    We thank Prof Ishihara for reviewing the manuscript, and are grateful for the constructive comments. There were some points to be addressed, as follows:

    How many times were the ... Continue reading
Views
22
Cite
Reviewer Report 29 Oct 2020
Virginia Lee, Department of Pathology and Laboratory Medicine, Institute on Aging and Center for Neurodegenerative Disease Research, The Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA 
Mandana Hunter, University of Pennsylvania, Philadelphia, PA, USA 
Approved with Reservations
VIEWS 22
In this manuscript from Eleanor Hobbs et al., the authors report the use of targeted locus amplification to identify the integration site of the NEFH-tTA transgene in B6;C3-Tg(NEFH-TTA)8Vle/J mice, which have been used in disease models for neuron-specific expression of ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Lee V and Hunter M. Reviewer Report For: A novel genotyping method to determine copy number in a mouse line commonly used for inducible transgene expression in brain and spinal cord [version 2; peer review: 1 approved, 2 approved with reservations]. F1000Research 2022, 9:1249 (https://doi.org/10.5256/f1000research.29310.r73226)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.
  • Author Response 10 Feb 2022
    Sarah Ryan, Division of Neuroscience and Experimental Psychology, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PL, UK
    10 Feb 2022
    Author Response
    We thank Prof Lee for reviewing the manuscript, and are grateful for the constructive comments. There were some points to be addressed, as follows:

    The reference to ‘copy number’ ... Continue reading
COMMENTS ON THIS REPORT
  • Author Response 10 Feb 2022
    Sarah Ryan, Division of Neuroscience and Experimental Psychology, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, M13 9PL, UK
    10 Feb 2022
    Author Response
    We thank Prof Lee for reviewing the manuscript, and are grateful for the constructive comments. There were some points to be addressed, as follows:

    The reference to ‘copy number’ ... Continue reading

Comments on this article Comments (0)

Version 2
VERSION 2 PUBLISHED 15 Oct 2020
Comment
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.